100.00% -13.60

Pieris Pharmaceuticals Inc (PIRS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Pieris Pharmaceuticals Inc Azioni (PIRS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	95.92% 0.053	1.299	19.52	20.05	1.936
Operating Expenses	7.66% 5.356	5.80	31.33	17.99	17.45
Benefits Costs and Expenses	100.00% -	67.35	-	-	-
Costs And Expenses	810.88% 5.356	0.588	31.33	17.99	17.45
Operating Income/Loss	17.82% -5.303	-4.501	-11.81	2.063	-15.51
Income/Loss From Continuing Operations Before Tax	100.08% 0.053	-66.06	19.52	20.05	1.936
Income/Loss From Continuing Operations After Tax	6.70% -4.892	-4.585	-10.75	3.976	-13.18
Net Income/Loss	6.72% -4.892	-4.584	-10.75	3.976	-13.18
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	58.36% 1.237	2.971	98.85	87.64	74.52
Basic Earnings Per Share	9,775% -3.95	-0.04	-0.11	0.05	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%